Anna Tylki-Szymańska

MedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland”.

Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland

Biomedicines(2023)10.3390/biomedicines11061668

N/A

0.457DataRank · unranked

13 citations

Beata Kieć‐Wilk, Łukasz Kałużny, Jolanta Wierzba, Anna Tylki-Szymańska, Zbigniew Żuber

Fifteen years of the Hunter Outcome Survey (HOS): Real-world insights into the patient population living with mucopolysaccharidosis type II (MPS II)

Molecular Genetics and Metabolism(2022)10.1016/j.ymgme.2021.11.223

N/A

0DataRank · unranked

0 citations

Maurizio Scarpa, Anna Tylki-Szymańska, Hernan Amartino, Paul Harmatz, Shuan-Pei Lin +10 more